Did you mean adx71149 of jnj 40411813 of adx 71149?
Displaying drugs 1 - 25 of 38 in total
Talquetamab
Talquetamab is a IgG4-PAA bispecific G protein-coupled receptor class C group 5 member D (GPRC5D)-directed CD3 T-cell engager. It consists of two arms - anti-GPRC5D and anti-CD3 arms - linked by two interchain disulfide bonds, each arm comprising a heavy and light chain. Talquetamab binds to GPRC5D, a cell surface...
Approved
Investigational
Matched Synonyms: … -63483043 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-63483043 .LAMBDA. ... PROLINE,239-ALANINE,240-ALANINE,410-LEUCINE,414-LYSINE), ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL JNJ …
Matched Description: … the EMA recommended conditional marketing authorization for talquetamab for the treatment of relapsed or …
Matched Description: … the EMA recommended conditional marketing authorization for talquetamab for the treatment of relapsed or …
Amivantamab
Amivantamab, also known as JNJ-61186372, is an anti-EGFR-MET bispecific antibody, derived from Chinese hamster ovary cells, approved for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose...
Approved
Investigational
Matched Description: … Amivantamab, also known as JNJ-61186372, is an anti-EGFR-MET bispecific antibody, derived from Chinese ... hamster ovary cells, approved for the treatment of adult patients with locally advanced or metastatic ... ) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or …
JNJ-40411813
JNJ-40411813 has been used in trials studying the treatment and basic science of Confusion, Schizophrenia, Perceptual Disorders, and Major Depressive Disorder.
Investigational
Matched Name: … JNJ-40411813 …
Matched Description: … JNJ-40411813 has been used in trials studying the treatment and basic science of Confusion, Schizophrenia …
Matched Description: … JNJ-40411813 has been used in trials studying the treatment and basic science of Confusion, Schizophrenia …
ADX-10061
ADX10061 is a potent, selective antagonist of the dopamine D1 receptor. It is developed by Addex Pharmaceuticals for the treatment of nicotine dependence.
Investigational
Matched Name: … ADX-10061 …
JNJ-38877605
JNJ-38877605 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Name: … JNJ-38877605 …
Matched Description: … JNJ-38877605 has been used in trials studying the treatment of Neoplasms. …
Matched Description: … JNJ-38877605 has been used in trials studying the treatment of Neoplasms. …
JNJ-42396302
Jnj 42396302 is under investigation in clinical trial NCT01732237 (A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants).
Investigational
Matched Name: … JNJ-42396302 …
Matched Description: … of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants). ... Jnj 42396302 is under investigation in clinical trial NCT01732237 (A Study to Investigate the Pharmacokinetics …
Matched Description: … of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants). ... Jnj 42396302 is under investigation in clinical trial NCT01732237 (A Study to Investigate the Pharmacokinetics …
JNJ-26489112
JNJ-26489112 is under investigation in clinical trial NCT00579384 (A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy).
Investigational
Matched Name: … JNJ-26489112 …
Matched Description: … JNJ-26489112 is under investigation in clinical trial NCT00579384 (A Study of the Effects of JNJ-26489112 …
Matched Description: … JNJ-26489112 is under investigation in clinical trial NCT00579384 (A Study of the Effects of JNJ-26489112 …
JNJ-54175446
JNJ-54175446 is under investigation in clinical trial NCT02933762 (A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma).
Investigational
Matched Name: … JNJ-54175446 …
Matched Description: … JNJ-54175446 is under investigation in clinical trial NCT02933762 (A Study in Healthy Participants to ... Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid …
Matched Description: … JNJ-54175446 is under investigation in clinical trial NCT02933762 (A Study in Healthy Participants to ... Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid …
JNJ-27390467
JNJ-27390467 is a potent, nonpeptide inhibitor of human mast cell tryptase.
Experimental
Matched Name: … JNJ-27390467 …
Matched Description: … JNJ-27390467 is a potent, nonpeptide inhibitor of human mast cell tryptase. …
Matched Description: … JNJ-27390467 is a potent, nonpeptide inhibitor of human mast cell tryptase. …
JNJ-39220675
JNJ-39220675 has been used in trials studying the treatment of Allergic Rhinitis.
Investigational
Matched Name: … JNJ-39220675 …
Matched Description: … JNJ-39220675 has been used in trials studying the treatment of Allergic Rhinitis. …
Matched Description: … JNJ-39220675 has been used in trials studying the treatment of Allergic Rhinitis. …
JNJ-40346527
JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.
Investigational
Matched Name: … JNJ-40346527 …
Matched Description: … JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid. …
Matched Description: … JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid. …
JNJ-28312141
Investigational
Matched Name: … JNJ-28312141 …
Matched Salts name: … JNJ-28312141 hydrochloride …
Matched Salts name: … JNJ-28312141 hydrochloride …
JNJ-75276617
JNJ-75276617 is under investigation in clinical trial NCT05453903 (A Study of JNJ-75276617 in Combination With Acute Myeloid Leukemia (AML) Directed Therapies).
Investigational
Matched Name: … JNJ-75276617 …
Matched Description: … JNJ-75276617 is under investigation in clinical trial NCT05453903 (A Study of JNJ-75276617 in Combination …
Matched Description: … JNJ-75276617 is under investigation in clinical trial NCT05453903 (A Study of JNJ-75276617 in Combination …
JNJ-42165279
Jnj-42165279 is under investigation in clinical trial NCT02498392 (An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress).
Investigational
Matched Name: … JNJ-42165279 …
Matched Description: … Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress). ... Jnj-42165279 is under investigation in clinical trial NCT02498392 (An Efficacy, Safety and Tolerability …
Matched Description: … Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress). ... Jnj-42165279 is under investigation in clinical trial NCT02498392 (An Efficacy, Safety and Tolerability …
JNJ-37822681
JNJ-37822681 has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Name: … JNJ-37822681 …
Matched Description: … JNJ-37822681 has been used in trials studying the treatment of Schizophrenia. …
Matched Description: … JNJ-37822681 has been used in trials studying the treatment of Schizophrenia. …
JNJ-39393406
JNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia, Smoking Cessation, Cognition Disorders, and Alzheimer's Disease.
Investigational
Matched Name: … JNJ-39393406 …
Matched Description: … JNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia …
Matched Description: … JNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia …
JNJ-41443532
JNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type 2.
Investigational
Matched Name: … JNJ-41443532 …
Matched Description: … JNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type …
Matched Description: … JNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type …
JNJ-28330835
A selective androgen receptor modulator with minimal prostate hypertrophic activity, enhances lean body mass in male rats and stimulates sexual behavior in female rats.
Experimental
Matched Name: … JNJ-28330835 …
JNJ-27548547
JNJ-27548547 is under investigation in clinical trial NCT01705002 (Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.).
Investigational
Matched Name: … JNJ-27548547 …
Matched Description: … JNJ-27548547 is under investigation in clinical trial NCT01705002 (Intravenously Administered Pegylated …
Matched Description: … JNJ-27548547 is under investigation in clinical trial NCT01705002 (Intravenously Administered Pegylated …
JNJ-17216498
JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment of narcolepsy.
Investigational
Matched Name: … JNJ-17216498 …
Matched Description: … JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment …
Matched Description: … JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment …
Reproxalap
Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
Investigational
Matched Synonyms: … ADX 102 …
Matched Description: … Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics …
Matched Description: … Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics …
Cetrelimab
Cetrelimab is under investigation in clinical trial NCT03547037 (A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers).
Investigational
Matched Synonyms: … JNJ-63723283 …
Matched Description: … -63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination ... NCT03547037 (A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ …
Matched Description: … -63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination ... NCT03547037 (A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ …
Pimodivir
Pimodivir is under investigation in clinical trial NCT02658825 (A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants).
Investigational
Matched Synonyms: … JNJ-63623872 …
Matched Description: … Pimodivir is under investigation in clinical trial NCT02658825 (A Study to Evaluate the Effect of JNJ …
Matched Description: … Pimodivir is under investigation in clinical trial NCT02658825 (A Study to Evaluate the Effect of JNJ …
Displaying drugs 1 - 25 of 38 in total